Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Gefitinib 184475-35-2

Gefitinib 184475-35-2

  Post Date: May 07,2019
  Expiry Date: Nov 03,2019
  Detailed Description: Cas No. :184475-35-2 Gefitinib is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. However, meta-analyses have not shown any improvement in overall survival, that is, it does not extend life.

  CAS Registry Number:


  Synonyms: ;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS);Gefitinib, Iressa, ZD1839;Gefitinib Base;Geftinib;
  Molecular Formula: C22H24ClFN4O3
  Molecular Weight: 446.9024
  Molecular Structure: 184475-35-2 Iressa

  Company: Shanghai Neopharm Co., Ltd.     [ China ]          
  Contact: Carol Zhu
  Tel: 021-58826758
  Fax: 021-58827258
  Email: sales@neopharm.com.cn
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.